Zou Yujing, Zhai Shanshan, Dong Jiawen, Zhao Tianyu, Yang Jin
School of Clinical Medicine, Hangzhou Normal University, Hangzhou, China.
Front Oncol. 2025 May 1;15:1495887. doi: 10.3389/fonc.2025.1495887. eCollection 2025.
Breast cancer imposes a substantial global health burden, with survivors frequently experiencing post-treatment quality of life deficits and chronic fatigue. While art therapy has gained recognition as a potential adjuvant intervention, its therapeutic value remains debated. To evaluate art therapy's efficacy, we conducted an exhaustive search of major electronic databases through October 2023, identifying 22 eligible RCTs reported in 22 papers that met predefined inclusion criteria from major databases including Web of Science Core Collection, Cochare, Embase, and Pubmed. Study quality was assessed using Cochrane risk-of-bias tools, with data extraction and analysis performed in RevMan 5.3. In this meta-analysis, we aimed to investigate the effect of art therapy on quality of life and fatigue in breast cancer patients. As of October 2023, relevant randomized controlled studies were searched from relevant electronic databases and articles were screened, quality evaluated, and data related to quality of life and fatigue were extracted and analysed using RevMan 5. 3. A total of 22 randomized controlled studies from 22 papers were included in this analysis. The results obtained according to this analysis included the effect of art on quality of life in breast cancer: SMD=0.38 (95% CI, 0.25 to 0.51; ≤0.00001), the fatigue-related indices: SMD=-0.03 (95% CI, -0.21 to 0.15; =0.73). The effect of intervention time less than two months: SMD=0.21 (95% CI, -0.01 to 0.43; =0.07), more than or equal to two months: SMD=0.45 (95% CI, 0.28 to 0.62; <0.00001). Different types of interventions: art therapy in painting and calligraphy: SMD=0.09 (95% CI, -0.17 to 0.35; =0.49), music-included art therapy: SMD=0.51 (95% CI, 0.32 to 0.70, <0.00001), music-out-of-treatment art therapy: SMD=0.44 (95% CI, 0.19 to 0.69; =0.0005). Follow-up time greater than or equal to six months: SMD=0.14 (95% CI, -0.09 to 0.36; =0.22), follow-up time less than six months: SMD=-0.34 (95% CI, -0.64 to -0.04; =0.03). In summary, this analysis demonstrated that art therapy improved quality of life, but the effects of fatigue reduction only occur within six months, with the degree of the benefits being correlated with the type, length, and timing of the intervention.
https://www.crd.york.ac.uk/PROSPERO/myprospero, identifier CRD42023476055.
乳腺癌给全球健康带来了沉重负担，幸存者经常经历治疗后生活质量下降和慢性疲劳。虽然艺术疗法已被公认为一种潜在的辅助干预措施，但其治疗价值仍存在争议。为了评估艺术疗法的疗效，我们对主要电子数据库进行了全面检索，截至2023年10月，共识别出22篇符合预定义纳入标准的随机对照试验（RCT），这些试验来自包括科学引文索引核心合集、Cochrane、Embase和PubMed在内的主要数据库。使用Cochrane偏倚风险工具评估研究质量，并在RevMan 5.3中进行数据提取和分析。在这项荟萃分析中，我们旨在研究艺术疗法对乳腺癌患者生活质量和疲劳的影响。截至2023年10月，从相关电子数据库中检索相关随机对照研究，并对文章进行筛选、质量评估，使用RevMan 5.3提取和分析与生活质量和疲劳相关的数据。本分析共纳入22篇论文中的22项随机对照研究。根据该分析得出的结果包括艺术对乳腺癌患者生活质量的影响：标准化均数差（SMD）=0.38（95%置信区间，0.25至0.51；P≤0.00001），与疲劳相关的指标：SMD=-0.03（95%置信区间，-0.21至0.15；P=0.73）。干预时间少于两个月：SMD=0.21（95%置信区间，-0.01至0.43；P=0.07），干预时间大于或等于两个月：SMD=0.45（95%置信区间，0.28至0.62；P<0.00001）。不同类型的干预措施：书画艺术疗法：SMD=0.09（95%置信区间，-0.17至0.35；P=0.49），包含音乐的艺术疗法：SMD=0.51（95%置信区间，0.32至0.70，P<0.00001），非治疗性音乐艺术疗法：SMD=0.44（95%置信区间，0.19至0.69；P=0.0005）。随访时间大于或等于六个月：SMD=0.14（95%置信区间，-0.09至0.36；P=0.22），随访时间少于六个月：SMD=-0.34（95%置信区间，-0.64至-0.04；P=0.03）。总之，该分析表明艺术疗法改善了生活质量，但减轻疲劳的效果仅在六个月内出现，益处程度与干预类型、时长和时机相关。
https://www.crd.york.ac.uk/PROSPERO/myprospero，标识符CRD42023476055。
